Flavin Mono-Oxygenase (FMO) - The ‘Other’ Oxidase

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|9|4|280-284

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.9, Iss.4, 2008-05, pp. : 280-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Flavin-Containing Monooxygenase (FMO) in the Metabolism of Tamoxifen and Other Tertiary Amines

By Krueger Sharon   VanDyke Jonathan   Williams David   Hines Ronald  

Drug Metabolism Reviews, Vol. 38, Iss. 1-2, 2006-05 ,pp. : 139-147

Informa Healthcare

Access to resources Recommend Favorite

Biochemical and Clinical Aspects of the Human Flavin-Containing Monooxygenase Form 3 (FMO3) Related to Trimethylaminuria

By  

Current Drug Metabolism, Vol. 4, Iss. 2, 2003-04 ,pp. : 151-170

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Polymorphism of the Flavin-Containing Monooxygenase 3 (FMO3) Associated with Trimethylaminuria (Fish Odor Syndrome): Observations from Japanese Patients

By  

Current Drug Metabolism, Vol. 8, Iss. 5, 2007-06 ,pp. : 487-491

Bentham Science Publishers

Access to resources Recommend Favorite

Peptidylglycine -Amidating Mono-Oxygenase - Inhibition of formation of peptide C-terminal amides

By Bolkenius F.N.   Ganzhorn A.J.  

General Pharmacology, Vol. 31, Iss. 5, 1998-11 ,pp. : 655-659

Elsevier

Access to resources Recommend Favorite

Flavin-containing monooxygenase 3 and human disease

By Motika Meike S   Zhang Jun   Cashman John R  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 3, Iss. 6, 2007-12 ,pp. : 831-845

Informa Healthcare

Access to resources Recommend Favorite